What DGI does

DGI, LLC is a not-for-profit Virginia limited liability company and a subsidiary of the Pharmaceutical Education and Research Institute, Inc. (PERI), operating the B.R.I.D.G.E. TO DATA® web platform (www.bridgetodata.org). The platform functions as a curated, subscription-access directory of standardized profiles for population healthcare databases worldwide, covering approximately 526 profiles across 73 countries in late 2025. Each profile is built from 135 defined data fields covering data collection methods, coding systems, population coverage, and administrative details, with more than 90% of profiles reviewed or updated by the underlying database managers. Product capabilities include keyword and criteria-based search, side-by-side profile comparison, saved searches, subscriber collections, an interactive geographic map, a proprietary glossary of international coding systems, and Excel export.

DGI monetizes the platform through tiered annual subscriptions segmented by user type: general/commercial users ($5,000-$13,333 list, currently discounted to $3,750-$10,000 under a '25 for 25' promotion), academia, regulators, government, and non-profits ($3,500-$8,000), database vendors ($4,500-$10,000), and a bulk B.R.I.D.G.E. Extract license at $50,000 (currently $40,000 under the same promotion), with multi-year prepayments receiving a 10% discount. A $1,000 thirty-day trial pass and a database landscaping consulting service (KOL identification, custom repositories, vendor communication) round out the commercial offering. Distribution is direct via the website and contact forms, supported by conference presence at ICPE, ISPOR, AcademyHealth, and OMOP-IMEDS, plus peer-reviewed publications, blog/email newsletters, LinkedIn, and customer testimonials. Named enterprise users include individuals from 8 of the top 10 pharma companies, the European Medicines Agency, Bayer, Travere Therapeutics, and Celldex Therapeutics, alongside academic and regulatory customers.

The company's history traces to the RAD-AR Handbooks (1988) and B.R.I.D.G.E. On-Line (2000), both consolidated and re-launched as the current B.R.I.D.G.E. TO DATA® platform in November 2009. The firm is privately held with no disclosed funding rounds, operates with a 1-10 employee headcount from Clifton, Virginia, and is steered by an eight-member advisory board spanning government, academia, and industry. Following the death of founding Executive Director Dr. Judith K. Jones in August 2020, editorial leadership passed to Sharmila Kamani, who oversees the team drafting and reviewing profiles.

Name

DGI

Legal name

DGI, LLC

Website

https://bridgetodata.org

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

1–10 employees

Short description

DGI, LLC operates B.R.I.D.G.E. TO DATA®, a subscription web platform providing standardized, expert-curated profiles of population healthcare databases worldwide (526+ profiles across 73 countries) for use by pharmaceutical companies, academic researchers, and regulatory bodies in pharmacoepidemiology and real-world evidence research.

Ownership category

akta.pro rank

Product category

Healthcare Database Metadata Platform

NAICS

Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (51821)

SIC

Services-Prepackaged Software (7372), Services-Computer Processing & Data Preparation (7374)

akta.pro primary industry

Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms (HLACAOAM)

akta.pro secondary industries

Data Governance, Standards & Interoperability (ICD, HL7/FHIR, LOINC, SNOMED) (HLAJAJAM), Real-World Data (RWD) Platforms & Clinical Data Curation (HLACAIAJ)

Keywords

• Healthcare database metadata
• Real-world evidence databases
• Pharmacoepidemiology research
• Population health databases
• Healthcare data landscaping

Headquarters

HQ city

Fairfax

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Subscription Access: Annual subscription-based access to the B.R.I.D.G.E. TO DATA platform providing searchable database profiles. Pricing tiers based on user count (up to 10, up to 20, unlimited) with different rates for general users, academia/government/non-profits, and database vendors. Multi-year subscriptions with pre-payment receive 10% discount.
2. Database Extract Licensing: Licensing of B.R.I.D.G.E. proprietary extract for organizations requiring bulk data access. Initial licensing with 10% discount for subsequent years of renewal.
3. Database Landscaping Services: Consulting services for data landscaping projects including comprehensive database searches, KOL identification, data source identification, vendor communication, and custom database repository development.
4. 30-Day Access Pass: Short-term subscription option for one month access allowing up to 5 users to browse approximately 450+ database profiles from 63+ countries, with option to upgrade to annual subscription.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

DGI, LLC operates B.R.I.D.G.E. TO DATA®, a web-based subscription platform that provides standardized profiles of population healthcare databases worldwide for use in epidemiology, drug safety, and health outcomes research. The platform covers 526+ database profiles across 73 countries, each structured with 135 defined data fields, enabling researchers to search, compare, and analyze population datasets for clinical, regulatory, and academic research. Beyond the subscription platform, DGI offers consulting services for data landscaping projects and licenses proprietary extracts of its database profile compendium.

Product overview

DGI, LLC operates as a not-for-profit organization (subsidiary of Pharmaceutical Education and Research Institute, Inc.) offering B.R.I.D.G.E. TO DATA® as its core product - a web-accessible searchable compendium of standardized population healthcare database profiles. The platform includes ~526 profiles from 73 countries covering various database types (longitudinal EMR, claims, registries, national surveys, surveillance systems, biobanks) with 135 data fields per profile. Beyond the core subscription platform, DGI offers consulting/database landscaping services and provides a proprietary glossary of international healthcare data terminology. Users can search, compare, save searches, create collections, and export results. The service serves pharmaceutical companies, academia, regulatory bodies, and public health researchers. Founded in 2009, the platform evolved from earlier RAD-AR Handbooks (1988) and B.R.I.D.G.E. On-Line (2000) services.

Differentiator

Problem solved

Functional benefit

Products and services

• B.R.I.D.G.E. TO DATA® Web-accessible subscription platform providing standardized in-depth profiles of population healthcare databases worldwide, covering ~526 database profiles from 73 countries with 135 defined data fields per profile for epidemiology and health outcomes research. Used by pharmaceutical companies, academic researchers, regulatory bodies, and CROs.
• Database Landscaping Services Consulting services assisting organizations with database-related projects, including comprehensive database searches, KOL identification, data source evaluation, vendor communication, data access facilitation, and customized searchable database repository development.
• B.R.I.D.G.E. Extract Licensed extract of B.R.I.D.G.E. database profiles available for organizations requiring bulk data access for analysis purposes, with annual licensing at $40,000-$50,000 (general users) and subsequent-year renewals receiving 10% discounts.

Quantifiable outcome

• 8 of top 10 pharmaceutical companies benefit from the B.R.I.D.G.E. TO DATA resource
• +2 more outcomes

Named customers8 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Pharmaceutical Education and Research Institute, Inc. (PERI)coreStrategic or Co-development PartnerDGI, LLC is a subsidiary of the Pharmaceutical Education and Research Institute, Inc. (PERI), a not-for-profit organization. This parent organization relationship provides the non-profit structure and educational mission for the B.R.I.D.G.E. TO DATA platform.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Emerging players

• COTA Healthcare: Oncology real-world data company curating deep EHR-derived datasets for pharma research. Comparable in building structured metadata catalogs about cancer databases and registries.
• HealthVerity: Healthcare data ecosystem that catalogs and links de-identified patient data across providers, payers, and labs for pharma research. Comparable in providing metadata-driven discovery over a distributed RWD landscape.
• Tempus: Precision medicine data company aggregating molecular and clinical data across oncology and other therapeutic areas. Comparable in producing structured metadata about databases for pharma research use cases.

Broad incumbents

• Flatiron Health: Oncology-focused real-world data and evidence company (Roche subsidiary) that curates deep profiles of cancer-specific databases. Comparable in building structured metadata about RWD sources for oncology research.
• ConcertAI: Oncology and biomedical RWD company that aggregates and curates multi-source clinical data for pharma research. Comparable in serving pharma RWE teams with metadata-driven data access.
• IQVIA: Largest CRO and healthcare data aggregator, providing proprietary RWD assets (claims, EMR, oncology) used by the same pharma customers as DGI. Multiple IQVIA database profiles are cataloged on B.R.I.D.G.E., confirming overlap.
• Optum: Largest US healthcare data and analytics business (UnitedHealth Group), offering claims, EMR, and linked data assets plus research consulting. Same customer base and overlapping RWE value proposition.

Others

• OHDSI / Observational Health Data Sciences and Informatics: Open-source collaborative that maintains the OMOP common data model and a global network of standardized observational databases. Provides a free, community-driven alternative for database discovery and analysis that could compete with DGI's curated approach.

Direct peers

• TriNetX: Global health research network cataloging hundreds of healthcare organizations and their datasets for clinical research. Operates a similar metadata catalog plus federated query layer for pharma-sponsored studies.
• Aetion: Real-world evidence analytics platform serving pharma regulatory and commercial use cases. Highly comparable to B.R.I.D.G.E. as both target pharma epidemiologists seeking RWD source identification and evidence generation, though Aetion layers analytics on top of chosen databases.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/dgi-llc

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DGI